Clinical-pharmacist intervention reduces clinically relevant drug–drug interactions in patients with heart failure: A randomized, double-blind, controlled trial
- 1 January 2016
- journal article
- research article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 203, 647-652
- https://doi.org/10.1016/j.ijcard.2015.10.206
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Hospital admissions/visits associated with drug–drug interactions: a systematic review and meta‐analysisPharmacoepidemiology and Drug Safety, 2014
- Clinical Pharmacy Services in Heart Failure: An Opinion Paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research NetworkPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- Clinical Usefulness of Electronic Drug-Drug Interaction Checking in the Care of Cardiovascular Surgery InpatientsCardiology, 2012
- Drug-Drug Interactions Associated with Length of Stay and Cost of HospitalizationJournal of Pharmacy & Pharmaceutical Sciences, 2009
- Evaluation of frequently used drug interaction screening programsInternational Journal of Clinical Pharmacy, 2008
- Clinical Pharmacy Services, Pharmacy Staffing, and Adverse Drug Reactions in United States HospitalsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2006
- Incidence and Possible Causes of Prescribing Potentially Hazardous/Contraindicated Drug Combinations in General PracticeDrug Safety, 2005
- The impact of critical care pharmacists on enhancing patient outcomesIntensive Care Medicine, 2003
- Hospital Admissions Resulting from Preventable Adverse Drug ReactionsAnnals of Pharmacotherapy, 2002
- Pharmacist Participation on Physician Rounds and Adverse Drug Events in the Intensive Care UnitJAMA, 1999